{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:01:08Z","timestamp":1790355668336,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Natural Science Foundation of China","award":["82303594"],"award-info":[{"award-number":["82303594"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Zhejiang Medical and Health Science and Technology Plan","award":["2024XY091"],"award-info":[{"award-number":["2024XY091"]}]},{"name":"Zhejiang Provincial County Level Advantageous Disciplines of Traditional Chinese Medicine Construction Plan","award":["2023-XK-D040"],"award-info":[{"award-number":["2023-XK-D040"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-026-03410-7","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:07:20Z","timestamp":1790309240000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["METTL16 promotes colorectal cancer progression and CD8+ T cell function through BCAT1-dependent branched-chain amino acid metabolism"],"prefix":"10.1007","volume":"43","author":[{"given":"Yanyan","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuedan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoju","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4454-956X","authenticated-orcid":false,"given":"Zejun","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"issue":"4","key":"3410_CR1","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.tips.2023.01.003","volume":"44","author":"AE Shin","year":"2023","unstructured":"Shin AE, Giancotti FG, Rustgi AK. Metastatic colorectal cancer: mechanisms and emerging therapeutics. Trends Pharmacol Sci. 2023;44(4):222\u201336.","journal-title":"Trends Pharmacol Sci"},{"key":"3410_CR2","doi-asserted-by":"publisher","first-page":"1403533","DOI":"10.3389\/fimmu.2024.1403533","volume":"15","author":"S Yan","year":"2024","unstructured":"Yan S, et al. Immune checkpoint inhibitors in colorectal cancer: limitation and challenges. Front Immunol. 2024;15:1403533.","journal-title":"Front Immunol"},{"issue":"9","key":"3410_CR3","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.tcb.2020.06.003","volume":"30","author":"M St Paul","year":"2020","unstructured":"St Paul M, Ohashi PS. The Roles of CD8(+) T Cell Subsets in Antitumor Immunity. Trends Cell Biol. 2020;30(9):695\u2013704.","journal-title":"Trends Cell Biol"},{"issue":"3","key":"3410_CR4","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/febs.16803","volume":"291","author":"X Li","year":"2024","unstructured":"Li X, Zhang HS. Amino acid metabolism, redox balance and epigenetic regulation in cancer. Febs j. 2024;291(3):412\u201329.","journal-title":"Febs j"},{"issue":"2","key":"3410_CR5","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ccell.2019.12.011","volume":"37","author":"S Sivanand","year":"2020","unstructured":"Sivanand S, Vander Heiden MG. Emerging Roles for Branched-Chain Amino Acid Metabolism in Cancer. Cancer Cell. 2020;37(2):147\u201356.","journal-title":"Cancer Cell"},{"issue":"3","key":"3410_CR6","doi-asserted-by":"publisher","first-page":"112186","DOI":"10.1016\/j.celrep.2023.112186","volume":"42","author":"CC Yao","year":"2023","unstructured":"Yao CC, et al. Accumulation of branched-chain amino acids reprograms glucose metabolism in CD8(+) T cells with enhanced effector function and anti-tumor response. Cell Rep. 2023;42(3):112186.","journal-title":"Cell Rep"},{"key":"3410_CR7","doi-asserted-by":"publisher","first-page":"113390","DOI":"10.1016\/j.biopha.2022.113390","volume":"153","author":"J Wang","year":"2022","unstructured":"Wang J, et al. The role of branched chain amino acids metabolic disorders in tumorigenesis and progression. Biomed Pharmacother. 2022;153:113390.","journal-title":"Biomed Pharmacother"},{"issue":"7","key":"3410_CR8","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1038\/s42255-023-00818-7","volume":"5","author":"L Qian","year":"2023","unstructured":"Qian L, et al. Enhanced BCAT1 activity and BCAA metabolism promotes RhoC activity in cancer progression. Nat Metab. 2023;5(7):1159\u201373.","journal-title":"Nat Metab"},{"issue":"5","key":"3410_CR9","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1002\/cam4.4525","volume":"11","author":"GS Li","year":"2022","unstructured":"Li GS, et al. BCAT1: A risk factor in multiple cancers based on a pan-cancer analysis. Cancer Med. 2022;11(5):1396\u2013412.","journal-title":"Cancer Med"},{"key":"3410_CR10","doi-asserted-by":"crossref","unstructured":"Ruszkowska A. METTL16, Methyltransferase-Like Protein 16: Current Insights into Structure and Function. Int J Mol Sci, 2021. 22(4):2176.","DOI":"10.3390\/ijms22042176"},{"issue":"2","key":"3410_CR11","doi-asserted-by":"publisher","first-page":"101758","DOI":"10.1016\/j.gendis.2025.101758","volume":"13","author":"K Qiu","year":"2026","unstructured":"Qiu K, et al. METTL16 in cancer: Roles and regulatory mechanisms. Genes Dis. 2026;13(2):101758.","journal-title":"Genes Dis"},{"issue":"16","key":"3410_CR12","doi-asserted-by":"publisher","first-page":"8444","DOI":"10.18632\/aging.204980","volume":"15","author":"A Wang","year":"2023","unstructured":"Wang A, et al. m(6)A methyltransferase METTL16 mediates immune evasion of colorectal cancer cells via epigenetically regulating PD-L1 expression. Aging. 2023;15(16):8444\u201357.","journal-title":"Aging"},{"issue":"5","key":"3410_CR13","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.cmet.2018.12.020","volume":"29","author":"RE Ericksen","year":"2019","unstructured":"Ericksen RE, et al. Loss of BCAA Catabolism during Carcinogenesis Enhances mTORC1 Activity and Promotes Tumor Development and Progression. Cell Metab. 2019;29(5):1151\u2013e11656.","journal-title":"Cell Metab"},{"issue":"2","key":"3410_CR14","doi-asserted-by":"publisher","first-page":"166941","DOI":"10.1016\/j.bbadis.2023.166941","volume":"1870","author":"ZR Kang","year":"2024","unstructured":"Kang ZR, et al. Deficiency of BCAT2-mediated branched-chain amino acid catabolism promotes colorectal cancer development. Biochim Biophys Acta Mol Basis Dis. 2024;1870(2):166941.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"5","key":"3410_CR15","doi-asserted-by":"publisher","first-page":"e13590","DOI":"10.1111\/cpr.13590","volume":"57","author":"J Li","year":"2024","unstructured":"Li J, et al. METTL16-mediated N6-methyladenosine modification of Soga1 enables proper chromosome segregation and chromosomal stability in colorectal cancer. Cell Prolif. 2024;57(5):e13590.","journal-title":"Cell Prolif"},{"issue":"4","key":"3410_CR16","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.7150\/ijbs.86719","volume":"20","author":"H Yu","year":"2024","unstructured":"Yu H, et al. METTL16 suppressed the proliferation and cisplatin-chemoresistance of bladder cancer by degrading PMEPA1 mRNA in a m6A manner through autophagy pathway. Int J Biol Sci. 2024;20(4):1471\u201391.","journal-title":"Int J Biol Sci"},{"key":"3410_CR17","doi-asserted-by":"publisher","first-page":"1138238","DOI":"10.3389\/fonc.2023.1138238","volume":"13","author":"F Xie","year":"2023","unstructured":"Xie F, et al. The m6A methyltransferase METTL16 inhibits the proliferation of pancreatic adenocarcinoma cancer cells via the p21 signaling pathway. Front Oncol. 2023;13:1138238.","journal-title":"Front Oncol"},{"issue":"14","key":"3410_CR18","doi-asserted-by":"publisher","first-page":"6602","DOI":"10.1111\/jcmm.16664","volume":"25","author":"XK Wang","year":"2021","unstructured":"Wang XK, et al. METTL16 promotes cell proliferation by up-regulating cyclin D1 expression in gastric cancer. J Cell Mol Med. 2021;25(14):6602\u201317.","journal-title":"J Cell Mol Med"},{"issue":"8","key":"3410_CR19","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1136\/gutjnl-2022-328845","volume":"72","author":"Y Bao","year":"2023","unstructured":"Bao Y, et al. Targeting m(6)A reader YTHDF1 augments antitumour immunity and boosts anti-PD-1 efficacy in colorectal cancer. Gut. 2023;72(8):1497\u2013509.","journal-title":"Gut"},{"issue":"4","key":"3410_CR20","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1053\/j.gastro.2022.06.024","volume":"163","author":"H Chen","year":"2022","unstructured":"Chen H, et al. METTL3 Inhibits Antitumor Immunity by Targeting m(6)A-BHLHE41-CXCL1\/CXCR2 Axis to Promote Colorectal Cancer. Gastroenterology. 2022;163(4):891\u2013907.","journal-title":"Gastroenterology"},{"key":"3410_CR21","doi-asserted-by":"publisher","first-page":"759020","DOI":"10.3389\/fcell.2022.759020","volume":"10","author":"L Lu","year":"2022","unstructured":"Lu L, et al. METTL16 predicts a favorable outcome and primes antitumor immunity in pancreatic ductal adenocarcinoma. Front Cell Dev Biol. 2022;10:759020.","journal-title":"Front Cell Dev Biol"},{"issue":"17","key":"3410_CR22","doi-asserted-by":"publisher","first-page":"e70060","DOI":"10.1111\/jcmm.70060","volume":"28","author":"Y Yang","year":"2024","unstructured":"Yang Y, et al. Multifaceted bioinformatic analysis of m6A-related ferroptosis and its link with gene signatures and tumour-infiltrating immune cells in gliomas. J Cell Mol Med. 2024;28(17):e70060.","journal-title":"J Cell Mol Med"},{"issue":"2","key":"3410_CR23","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1002\/cam4.5008","volume":"12","author":"SK Pedersen","year":"2023","unstructured":"Pedersen SK, et al. Detection of methylated BCAT1 and IKZF1 after curative-intent treatment as a prognostic indicator for colorectal cancer recurrence. Cancer Med. 2023;12(2):1319\u201329.","journal-title":"Cancer Med"},{"issue":"10","key":"3410_CR24","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1002\/cncr.34159","volume":"128","author":"SK Pedersen","year":"2022","unstructured":"Pedersen SK, et al. Detection of recurrent colorectal cancer with high specificity using a reporting threshold for circulating tumor DNA methylated in BCAT1 and IKZF1. Cancer. 2022;128(10):1921\u20138.","journal-title":"Cancer"},{"key":"3410_CR25","doi-asserted-by":"crossref","unstructured":"Zhang Y et al. Amino acids and RagD potentiate mTORC1 activation in CD8(+) T cells to confer antitumor immunity. J Immunother Cancer, 2021. 9(4):e002137.","DOI":"10.1136\/jitc-2020-002137"},{"issue":"2","key":"3410_CR26","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.cmet.2020.06.010","volume":"32","author":"B Kelly","year":"2020","unstructured":"Kelly B, Pearce EL. Amino Assets: How Amino Acids Support Immunity. Cell Metab. 2020;32(2):154\u201375.","journal-title":"Cell Metab"},{"issue":"1","key":"3410_CR27","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41577-019-0203-y","volume":"20","author":"NM Chapman","year":"2020","unstructured":"Chapman NM, Boothby MR, Chi H. Metabolic coordination of T cell quiescence and activation. Nat Rev Immunol. 2020;20(1):55\u201370.","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"3410_CR28","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1093\/neuonc\/noad190","volume":"26","author":"P Boskovic","year":"2024","unstructured":"Boskovic P, et al. Branched-chain amino acid transaminase 1 regulates glioblastoma cell plasticity and contributes to immunosuppression. Neuro Oncol. 2024;26(2):251\u201365.","journal-title":"Neuro Oncol"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03410-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03410-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03410-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:03:21Z","timestamp":1790352201000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-026-03410-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":28,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["3410"],"URL":"https:\/\/doi.org\/10.1007\/s12032-026-03410-7","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"assertion":[{"value":"8 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have declared that no competing interest exists.All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Ethics Committee of Sanmen People\u2019s Hospital (No.2025-063). All animal protocols followed NIH animal care guidelines and were approved by the Institutional Animal Care and Use Committee of Zhejiang Baiyue Biology technology (Approval No.: ZJBYLA-IACUC-20241127).","order":3,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this work the authors did not use any AI-assisted technology.","order":4,"name":"Ethics","label":"Generative AI and AI-assisted technologies in the writing process","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"295"}}